Dodge & Cox Stock Fund Humana Inc transactions over time
HUM
Humana Inc historical holders
total: 16
Transactions details
- Total transactions:
- 6
- New positions:
- 1
- Added:
- 4
- Reduced:
- 1
- Held since:
- 2024 Q2
- Held for:
- 9 quarters
- Latest activity:
- 2026 Q2
Dodge & Cox Stock Fund has been an institutional investor in Humana Inc (HUM) since 2024 Q2. According to 2026 Q2 report, Dodge & Cox Stock Fund holds 7,354,500 shares with a market value of roughly $2.92B representing 2.47% of their equity portfolio. The fund/company first acquired HUM in 2024 Q2, initially purchasing about 2.88M shares. Since the initial investment, Dodge & Cox Stock Fund has made 5 more transactions in this position.
Does Dodge & Cox Stock Fund still hold HUM?
Yes, Dodge & Cox Stock Fund continues to hold Humana Inc (HUM). According to their 2026 Q2 report, they maintain a position of 7,354,500 shares valued at approximately $2.92B, representing 2.47% of their equity portfolio.
When did Dodge & Cox Stock Fund first invest in HUM?
Dodge & Cox Stock Fund first invested in Humana Inc (HUM) in 2024 Q2 at the reported quarter-end price of $373.65 per share, acquiring 2,880,956 shares in their initial purchase.
What is Dodge & Cox Stock Fund's average cost basis for HUM?
Based on historical transaction data, Dodge & Cox Stock Fund's estimated cost basis for Humana Inc (HUM) is approximately $303.08 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $303.08
- Weighted AVG sell price:
- $397.22
HUM transactions history by Dodge & Cox Stock Fund
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.47%
|
7,354,500
|
$397.22
|
$2,921,354,490
|
-2.61% (-197,000)
|
-0.07%
|
|
2025 Q2
|
1.57%
|
7,551,500
|
$244.48
|
$1,846,190,720
|
+5.17% (+371,000)
|
+0.08%
|
|
2025 Q1
|
1.67%
|
7,180,500
|
$264.60
|
$1,899,960,300
|
+5.24% (+357,300)
|
+0.08%
|
|
2024 Q4
|
1.55%
|
6,823,200
|
$253.71
|
$1,731,114,072
|
+106.34% (+3,516,400)
|
+0.8%
|
|
2024 Q3
|
0.91%
|
3,306,800
|
$316.74
|
$1,047,395,832
|
+14.78% (+425,844)
|
+0.12%
|
|
2024 Q2
|
0.99%
|
2,880,956
|
$373.65
|
$1,076,469,209
|
new
|
+0.99%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.